SCHEMBL6499764

SCHEMBL6499764

CN(C)c1ccc(/C=C/C(=O)O)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 1/20 0.52
ICAM1 P05362 1/20 0.52
ITGAL P20701 1/20 0.52
KDM4E B2RXH2 6/20 0.49
MAPK1 P28482 4/20 0.49
ALDH1A1 P00352 4/20 0.49
CA1 P00915 4/20 0.49
CA2 P00918 4/20 0.49
HSD17B10 Q99714 3/20 0.49
HPGD P15428 3/20 0.49
CA12 O43570 3/20 0.49
CA3 P07451 3/20 0.49
CA4 P22748 3/20 0.49
CA6 P23280 3/20 0.49
CA5A P35218 3/20 0.49
CA7 P43166 3/20 0.49
CA9 Q16790 3/20 0.49
CA14 Q9ULX7 3/20 0.49
CA5B Q9Y2D0 3/20 0.49
LMNA P02545 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499766 1.00 ITGB2 (0.52) ITGB2ICAM1ITGALKDM4EMAPK1
SCHEMBL19508587 0.89 HSD17B3 (0.54) MAPK1ALDH1A1CA1CA2HPGD
SCHEMBL13879637 0.81 NPC1 (0.54) ITGB2ICAM1ITGALALDH1A1APP
SCHEMBL1124516 0.79 PYGL (0.62) ITGB2ICAM1ITGALKDM4EMAPK1
SCHEMBL7828903 0.79 PYGL (0.62) ITGB2ICAM1ITGALKDM4EMAPK1
SCHEMBL1124517 0.79 PYGL (0.62) ITGB2ICAM1ITGALKDM4EMAPK1
SCHEMBL13879640 0.79 PYGL (0.62) ITGB2ICAM1ITGALKDM4EALDH1A1
SCHEMBL7003267 0.78 PKM (0.60) ITGB2ICAM1ITGALKDM4EMAPK1
SCHEMBL7003269 0.78 PKM (0.60) ITGB2ICAM1ITGALKDM4EMAPK1
SCHEMBL13879635 0.78 ALDH1A1 (0.56) ITGB2ICAM1ITGALKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed